KAKZF yields 6.67% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, KAKZF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KAKZF + PFE for your $10,000?
Joint Stock Company Kaspi.kz, together with its subsidiaries, provides financial services primarily through the online mobile app in the Republic of Kazakhstan. The company operates through three segments: Payments Platform, Marketplace Platform, and Fintech Platform. The Payments Platform segment connects its customers comprising consumer and merchants to facilitate cashless and digital payment transactions. This segment also offers a technology platform to pay and receive payments for goods and services, as well as to transfer and withdraw money. The Marketplace Platform segment connects merchants and consumers enabling merchants to enhance its sales and enable consumers to buy a selection of products and services from various merchants. The Fintech Platform segment enables its consumers to manage its personal finances online and access consumer finance and deposit products primarily through the Kaspi.kz Super App. It is also involved in the e-commerce, banking, insurance, and asset management services; real estate business; and provision of online travel and payment processing services. The company was incorporated in 2008 and is based in Almaty, the Republic of Kazakhstan.
Full KAKZF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.